Efficacy of Trichloroacetic Acid 70% After Microneedling versus Intralesional Triamcinolone Acetonide Injection in the Treatment of Non-segmental Vitiligo: Comparative study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202508513182931

Enrollment

Registered

2025-08-11

Start date

2024-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

TA Group

TCA after microneedling group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: localized vitiligo over one year

Exclusion criteria

Exclusion criteria: vitiligo treatments within the past 3 months bleeding tendency, or on anticoagulant therapy individuals with a present or past history of cutaneous malignancy, moles, warts, or solar keratosis. Patients with a history of eczema, impetigo, herpes labialis, lichen planus, or psoriasis

Design outcomes

Primary

Measure	Time frame
The degree of repigmentation was evaluated using a 5-point Physician’s Global Assessment (PGA) scale	—

Secondary

Measure	Time frame
side effects from the procedure	—

Countries

Egypt

Contacts

Public ContactIbrahim Shaheen

Professor of Dermatology Venereology and Andrology

ibshaheen@yahoo.com00201012918083

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026